China Pharma Holdings (CHPI) Return on Assets ROA from the second quarter of 2012 to second quarter of 2011 and for the year 2012, Average High and Low, Fundamental Ratios from Jun 30 2012 to Jun 30 2011 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
China Pharma Holdings, Inc.  (CHPI)


China Pharma Holdings's ROA from the second quarter of 2012 to the second quarter of 2011 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is China Pharma Holdings's ROA in the second quarter of 2012?
China Pharma Holdings, Inc. achieved a return on average assets (ROA) of 12.79 % in its second quarter of 2012, which is below China Pharma Holdings's average return on assets, which stands at 13.03%.

ROA decreased relative to the period ending Mar 31 2012, due to the decline in net income.

However, within the Healthcare sector 73 other companies had a higher return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2012 at no. .

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter		 (Jun 30 2011)
II. Quarter
Y / Y Total Assets Change 26.23 % 70.79 % - - -
Y / Y Net Income Change - 14.31 % -39.82 % 3.76 % -
Net Income (TTM) in million 1 2 2 3 3
Return On Assets (TTM) 12.79 % 26.92 % 29.56 % 44.79 % 71.87 %
CHPI's Total Ranking # # # # #
Total Assets (TTM) in million 10 10 8 9 8
Seq. Total Assets Change -0.92 % 20.94 % -2.27 % 7.79 % 34.06 %
Seq. Net Income Change - 76.92 % -34.96 % -33.07 % 48.41 %

CHPI's 5 Years Annual ROA >> Back to CHPI Management Effectiveness >> Compare CHPI ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 30
Sector # 74
Overall # 445

Return On Assets Statistics
High Average Low
13.03 %
13.03 %
13.03 %
(Jun 30 2012)  





Financial Statements
China Pharma Holdings's Assets $ 10 million CHPI's Balance sheet
China Pharma Holdings's Income $ 0 million Quarterly CHPI's Income Statement
CHPI's Income by Division See CHPI's Income by Division



Annual Return On Assets (Dec 31 2010)
FY 2011
FY
FY
FY
FY
Y / Y Total Assets Change - - - - -
Total Assets in million 6 0 0 0 0
Y / Y Net Income Change - - - - -
Net Income in million 2 0 0 0 0
Annual Return On Assets 28.89 % - - - -

CHPI's 5 Years Annual ROA >> Back to CHPI Management Effectiveness >> Compare CHPI ROA to its Competitors



Comment on CHPI's ROA in the fiscal year ending 2011
In the fiscal year 2011 ROA improved to 28.89 % compared to prior year, due to annual net income growth of % to $1.74 million, while value of China Pharma Holdings's overall assets grew just by % to $6.02 million, compared to $6.02 a year before.


More Return On Assets Ratios
CHPI's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CHPI's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CHPI's Competitors
Subscribers only: Roa for China Pharma Holdings's Suppliers
Subscribers only: Return On Assets for CHPI's Customers

You may also want to know
CHPI's Roi CHPI's Inventory Turnover Ratio CHPI's Growth Rates CHPI's Dividend Comparisons
CHPI's Profitability Ratios CHPI's Asset Turnover Ratio CHPI's Dividend Growth
CHPI's Roe CHPI's Valuation Ratios CHPI's Financial Strength Ratios CHPI's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2012, within Healthcare Sector ROA
Vaso Corporation  35.06 %
Veru Inc   34.88 %
Spectrum Pharmaceuticals Inc   29.38 %
Vertex Pharmaceuticals Inc  20.33 %
Meridian Bioscience Inc   20.08 %
U S Physical Therapy Inc  18.83 %
United Therapeutics Corporation  18.56 %
Bio techne Corp  17.95 %
Intuitive Surgical Inc   17.92 %
Neurocrine Biosciences Inc   17.91 %
Idexx Laboratories Inc  17.60 %
Jazz Pharmaceuticals Plc  16.34 %
Medicines Co  15.62 %
Exelixis Inc   15.46 %
Celgene Corp  15.33 %
Waters Corporation  15.33 %
Biogen Inc   14.85 %
Gilead Sciences Inc   14.45 %
Healthcare Services Group Inc   13.83 %
Varian Medical Systems Inc   13.53 %
3m Company  13.49 %
Bard C R Inc  13.47 %
Utah Medical Products Inc  13.40 %
Mettler toledo International Inc   13.08 %
China Pharma Holdings, Inc.  13.03 %
Hca Healthcare Inc   12.63 %
Baxter International Inc   12.40 %
Allergan plc  12.39 %
Eli Lilly And Company  12.33 %
Bristol myers Squibb Company  12.23 %

Date modified: 2026-09-02T20:25:00+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.